Side-effect profile is similar to GLP-1 agonists
Current areas of scientific investigation include dual incretin receptor signaling studies, metabolic regulation research, glucose pathway investigation, appetite-associated signaling analysis, lipid metabolism studies, and peptide-receptor interaction research
The tirzepatide conversion chart provides additional context for dose translations between different formulations and concentrations
Nausea, diarrhea, vomiting, constipation, dyspepsia, abdominal pain, fatigue, hypersensitivity reactions, burping, hair loss, and gastroesophageal reflux disease (GERD) may occur
They are ideal for individuals with obesity or weight-related medical conditions, making them a great option for anyone looking to improve their health through weight management